Epoetin alfa prevents, treats chemotherapy-induced anemia

07/19/2013 | MedPage Today (free registration)

Prophylactic epoetin alfa eased anemia during aggressive chemotherapy for breast cancer, a study found. However, 7% of the epoetin alfa-treated patients had thrombotic events, compared with 3% in a control group. "With the exception of this risk, erythropoiesis-stimulating agents appear to be safe drugs for the treatment of chemotherapy-induced anemia or the primary prevention of anemia in patients with intensive dose-dense chemotherapy regimens," according to the report in the Journal of the National Cancer Institute.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC